AMY GRAFA: Open Payments
NPI 1922777838 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,295 in 121 payments from 19 companies in 2025. Trend: 2023 $1,628 · 2024 $1,587 · 2025 $2,295
Food & beverage: $2,295
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $355 |
| Galderma Laboratories, L.P. | 13 | $281 |
| Janssen Biotech, Inc. | 15 | $277 |
| GENZYME CORPORATION | 14 | $262 |
| Arcutis Biotherapeutics, Inc. | 24 | $242 |
| Regeneron Healthcare Solutions, Inc. | 10 | $180 |
| Novartis Pharmaceuticals Corporation | 7 | $167 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $93 |
| LEO Pharma Inc. | 5 | $90 |
| Almirall LLC | 3 | $81 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, Zoryve, SKYRIZI, RINVOQ, COSENTYX, Bimzelx.
Industry payments across TX — which companies pay providers there.
